Post-earnings recap
Reported
Mon, Jul 21, 2008
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Boston Scientific reported an EPS of $0.20, significantly beating expectations. However, the stock reacted negatively, declining by 0.65%. The lack of revenue data and management commentary may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.20 | N/A | +80.18% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—